Autoimmune Hepatitis Clinical Trial
Official title:
A Randomized, Open-label, Multiple-dose, Two-period, Crossover, Study to Investigate the Pharmacokinetic Profile of 2 Formulations of JKB-122 in Healthy Male Subjects
The purpose of this study is to compare the pharmacokinetics of JKB-122 tablets with JKB-122 capsules in healthy male subjects subjects.
This clinical study will be a randomized, open-label, multiple-dose, two-period, crossover study in healthy male subjects. After screening, subjects will be randomized to receive either JKB-122 tablet or JKB-122 capsule in a 1:1 ratio. There will be two dosing periods (Period 1 and Period 2). Subjects who receive JKB-122 capsule during Period 1 will receive JKB-122 tablet during Period 2 and vice versa. The 2 dosing periods will be separated by a washout period. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06020976 -
Pattern of Autoimmune Hepatitis in Children In Sohag University Hospital
|
||
| Recruiting |
NCT05476900 -
A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.
|
Phase 2 | |
| Recruiting |
NCT05635266 -
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
|
||
| Recruiting |
NCT06250309 -
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
|
N/A | |
| Recruiting |
NCT01661842 -
Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis
|
Phase 1/Phase 2 | |
| Terminated |
NCT04339621 -
AIH Risk Stratification With Multiparametric MRI
|
||
| Not yet recruiting |
NCT04371718 -
Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)
|
Phase 2 | |
| Completed |
NCT02239562 -
sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS
|
Phase 1 | |
| Recruiting |
NCT05569759 -
A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)
|
Phase 2 | |
| Completed |
NCT02463331 -
Association of Chloroquine and Prednisone as an Alternative Treatment for Autoimmune Hepatitis
|
Phase 4 | |
| Not yet recruiting |
NCT06356506 -
A Study on Factors of Biochemical Response in Autoimmune Hepatitis
|
||
| Terminated |
NCT04203875 -
Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis
|
Phase 1 | |
| Recruiting |
NCT06078098 -
Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
|
||
| Completed |
NCT00838214 -
Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05810480 -
PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G
|
||
| Recruiting |
NCT03743272 -
Repeatability and Reproducibility of Multiparametric MRI
|
||
| Completed |
NCT03979053 -
Quantitative Magnetic Resonance Imaging to Aid Clinical Decision Making in Autoimmune Hepatitis.
|
||
| Not yet recruiting |
NCT04902807 -
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
|
||
| Recruiting |
NCT04933292 -
A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome
|
Phase 4 | |
| Not yet recruiting |
NCT06455280 -
SIPLIZUMAB in AILD and LT
|
Phase 1 |